CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 89 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $25,000 | -51.9% | 1,500 | -25.0% | 0.01% | -55.2% |
| Q4 2017 | $52,000 | +246.7% | 2,000 | +100.0% | 0.03% | +222.2% |
| Q3 2017 | $15,000 | +7.1% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $14,000 | -46.2% | 1,000 | -33.3% | 0.01% | -43.8% |
| Q1 2017 | $26,000 | +23.8% | 1,500 | -25.0% | 0.02% | +23.1% |
| Q4 2016 | $21,000 | +5.0% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $20,000 | +17.6% | 2,000 | +33.3% | 0.01% | +8.3% |
| Q2 2016 | $17,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |